No Data
No Data
HPGC Renmintongtai Pharmaceutical (SHSE:600829) May Have Issues Allocating Its Capital
Despite Delivering Investors Losses of 18% Over the Past 5 Years, HPGC Renmintongtai Pharmaceutical (SHSE:600829) Has Been Growing Its Earnings
Half-year report for the year 2024.
Summary of Half-Year Report in 2024.
HPGC Renmintongtai Pharmaceutical Corporation (600829.SH) has released its first-half performance, with a net income of 0.135 billion yuan, a decrease of 11.84% compared to the same period last year.
HPGC Renmintongtai Pharmaceutical Corporation (stock code: 600829.SH) released its semi-annual report for 2024, reporting a revenue of 4...
HPGC Renmintongtai Pharmaceutical Corporation (SHSE:600829) Will Pay A CN¥0.144 Dividend In Two Days
No Data
No Data